 Natalie Nokoff
Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transgender Persons | 8 | 2023 | 135 | 3.340 |
Why?
| | Adrenal Hyperplasia, Congenital | 9 | 2023 | 29 | 2.790 |
Why?
| | Disorders of Sex Development | 11 | 2021 | 37 | 2.450 |
Why?
| | Gender Dysphoria | 4 | 2023 | 14 | 1.420 |
Why?
| | Insulin Resistance | 3 | 2020 | 1180 | 1.020 |
Why?
| | Genitalia | 6 | 2021 | 27 | 0.930 |
Why?
| | Neurodevelopmental Disorders | 2 | 2021 | 116 | 0.900 |
Why?
| | Athletic Performance | 1 | 2023 | 46 | 0.870 |
Why?
| | Caregivers | 5 | 2022 | 709 | 0.800 |
Why?
| | Testosterone | 7 | 2023 | 351 | 0.800 |
Why?
| | Adrenal Insufficiency | 2 | 2021 | 30 | 0.790 |
Why?
| | Genital Diseases, Female | 2 | 2021 | 28 | 0.780 |
Why?
| | Mood Disorders | 1 | 2021 | 119 | 0.760 |
Why?
| | Cardiovascular Diseases | 3 | 2022 | 1798 | 0.730 |
Why?
| | Anxiety | 4 | 2023 | 845 | 0.690 |
Why?
| | Parents | 8 | 2022 | 1212 | 0.690 |
Why?
| | Body Composition | 2 | 2020 | 653 | 0.680 |
Why?
| | Puberty | 2 | 2019 | 144 | 0.680 |
Why?
| | Urogenital Surgical Procedures | 3 | 2020 | 5 | 0.680 |
Why?
| | Turner Syndrome | 4 | 2023 | 50 | 0.650 |
Why?
| | Gonadal Steroid Hormones | 1 | 2019 | 122 | 0.650 |
Why?
| | Genital Diseases, Male | 1 | 2016 | 15 | 0.580 |
Why?
| | Hypertension | 2 | 2022 | 1203 | 0.580 |
Why?
| | Adolescent | 18 | 2023 | 18480 | 0.490 |
Why?
| | Mental Disorders | 2 | 2021 | 939 | 0.470 |
Why?
| | Child | 23 | 2023 | 19129 | 0.460 |
Why?
| | Biomarkers | 3 | 2021 | 3588 | 0.460 |
Why?
| | Emergencies | 1 | 2014 | 153 | 0.450 |
Why?
| | Body Mass Index | 1 | 2020 | 2092 | 0.420 |
Why?
| | Female | 37 | 2023 | 61565 | 0.420 |
Why?
| | Male | 32 | 2023 | 57801 | 0.420 |
Why?
| | Ambulatory Care Facilities | 1 | 2014 | 218 | 0.420 |
Why?
| | Estradiol | 4 | 2023 | 476 | 0.410 |
Why?
| | Humans | 48 | 2023 | 118974 | 0.410 |
Why?
| | Acute Disease | 1 | 2014 | 940 | 0.390 |
Why?
| | Obesity | 3 | 2022 | 2746 | 0.390 |
Why?
| | Sexual Development | 6 | 2023 | 20 | 0.380 |
Why?
| | Propensity Score | 2 | 2021 | 242 | 0.370 |
Why?
| | Child, Preschool | 11 | 2021 | 9491 | 0.360 |
Why?
| | Insulin | 1 | 2019 | 2162 | 0.350 |
Why?
| | Infant | 11 | 2022 | 8293 | 0.350 |
Why?
| | Case-Control Studies | 3 | 2021 | 3171 | 0.350 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 323 | 0.340 |
Why?
| | Odds Ratio | 2 | 2021 | 996 | 0.330 |
Why?
| | Sex Characteristics | 3 | 2023 | 671 | 0.320 |
Why?
| | Patient Acceptance of Health Care | 1 | 2014 | 687 | 0.320 |
Why?
| | Electronic Health Records | 3 | 2023 | 829 | 0.300 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 4552 | 0.300 |
Why?
| | Quality of Life | 7 | 2021 | 2366 | 0.290 |
Why?
| | Genetic Predisposition to Disease | 3 | 2019 | 2275 | 0.280 |
Why?
| | Logistic Models | 2 | 2021 | 1901 | 0.280 |
Why?
| | Pediatrics | 1 | 2014 | 985 | 0.280 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2013 | 3360 | 0.280 |
Why?
| | Autoimmunity | 1 | 2012 | 831 | 0.270 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2014 | 1185 | 0.270 |
Why?
| | Gender Identity | 3 | 2020 | 102 | 0.240 |
Why?
| | Genitalia, Female | 2 | 2021 | 40 | 0.240 |
Why?
| | Primary Health Care | 1 | 2014 | 1560 | 0.230 |
Why?
| | Risk Factors | 5 | 2021 | 9000 | 0.230 |
Why?
| | Emergency Service, Hospital | 1 | 2014 | 1865 | 0.220 |
Why?
| | Testosterone Congeners | 1 | 2022 | 8 | 0.220 |
Why?
| | Leuprolide | 1 | 2022 | 20 | 0.220 |
Why?
| | Uncertainty | 2 | 2020 | 101 | 0.210 |
Why?
| | Androgens | 1 | 2023 | 167 | 0.210 |
Why?
| | Overweight | 2 | 2022 | 502 | 0.200 |
Why?
| | Adaptation, Psychological | 2 | 2016 | 557 | 0.200 |
Why?
| | Wnt4 Protein | 1 | 2021 | 18 | 0.200 |
Why?
| | Klinefelter Syndrome | 1 | 2022 | 53 | 0.200 |
Why?
| | Infant, Newborn | 3 | 2021 | 5255 | 0.200 |
Why?
| | Monosomy | 1 | 2021 | 10 | 0.200 |
Why?
| | Young Adult | 6 | 2023 | 10793 | 0.200 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 193 | 0.200 |
Why?
| | Sex Chromosome Aberrations | 1 | 2021 | 53 | 0.190 |
Why?
| | Decision Making | 3 | 2022 | 809 | 0.190 |
Why?
| | Dyslipidemias | 1 | 2022 | 162 | 0.190 |
Why?
| | Child Behavior Disorders | 1 | 2021 | 129 | 0.180 |
Why?
| | Athletes | 1 | 2023 | 353 | 0.180 |
Why?
| | Sex Hormone-Binding Globulin | 1 | 2019 | 49 | 0.180 |
Why?
| | Liver Diseases | 1 | 2022 | 282 | 0.180 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 80 | 0.180 |
Why?
| | Sexual Maturation | 1 | 2019 | 51 | 0.180 |
Why?
| | Growth Hormone | 1 | 2019 | 108 | 0.180 |
Why?
| | Inservice Training | 1 | 2020 | 106 | 0.180 |
Why?
| | Capillaries | 1 | 2019 | 103 | 0.170 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2021 | 117 | 0.170 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2019 | 765 | 0.170 |
Why?
| | Postmenopause | 1 | 2021 | 305 | 0.170 |
Why?
| | Vascular Malformations | 1 | 2019 | 47 | 0.170 |
Why?
| | Women's Health | 1 | 2021 | 274 | 0.170 |
Why?
| | Reproductive Health | 1 | 2019 | 68 | 0.170 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2021 | 157 | 0.170 |
Why?
| | Phosphoproteins | 1 | 2021 | 308 | 0.170 |
Why?
| | Mentors | 1 | 2020 | 166 | 0.160 |
Why?
| | Developmental Disabilities | 1 | 2021 | 247 | 0.160 |
Why?
| | Mentoring | 1 | 2020 | 101 | 0.160 |
Why?
| | Sexual and Gender Minorities | 1 | 2021 | 137 | 0.160 |
Why?
| | Parent-Child Relations | 2 | 2019 | 232 | 0.160 |
Why?
| | Erythrocytes | 1 | 2023 | 641 | 0.160 |
Why?
| | Interprofessional Relations | 1 | 2020 | 261 | 0.160 |
Why?
| | Anxiety Disorders | 2 | 2023 | 309 | 0.150 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 241 | 0.150 |
Why?
| | Emotional Adjustment | 1 | 2017 | 18 | 0.150 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 48 | 0.150 |
Why?
| | Diabetic Nephropathies | 1 | 2020 | 289 | 0.150 |
Why?
| | Metformin | 1 | 2021 | 295 | 0.150 |
Why?
| | Linear Models | 1 | 2019 | 827 | 0.150 |
Why?
| | Academic Medical Centers | 1 | 2019 | 422 | 0.140 |
Why?
| | Adult | 10 | 2023 | 31512 | 0.140 |
Why?
| | Hemodynamics | 1 | 2021 | 1004 | 0.140 |
Why?
| | Analysis of Variance | 1 | 2019 | 1293 | 0.140 |
Why?
| | Databases, Factual | 1 | 2021 | 1231 | 0.140 |
Why?
| | Perception | 1 | 2018 | 314 | 0.140 |
Why?
| | Prospective Studies | 5 | 2021 | 6471 | 0.140 |
Why?
| | Students, Medical | 1 | 2021 | 311 | 0.140 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 505 | 0.140 |
Why?
| | Adipose Tissue | 1 | 2020 | 606 | 0.140 |
Why?
| | Urologic Surgical Procedures | 1 | 2016 | 94 | 0.130 |
Why?
| | Pilot Projects | 1 | 2020 | 1419 | 0.130 |
Why?
| | Hypopituitarism | 1 | 2015 | 15 | 0.130 |
Why?
| | Hypoglycemia | 1 | 2019 | 400 | 0.130 |
Why?
| | Prognosis | 2 | 2020 | 3443 | 0.130 |
Why?
| | Longitudinal Studies | 4 | 2023 | 2513 | 0.120 |
Why?
| | Stress, Psychological | 2 | 2019 | 972 | 0.120 |
Why?
| | Sex Factors | 1 | 2019 | 1781 | 0.120 |
Why?
| | Kidney | 1 | 2021 | 1353 | 0.120 |
Why?
| | Follow-Up Studies | 2 | 2020 | 4596 | 0.120 |
Why?
| | Depressive Disorder | 1 | 2015 | 333 | 0.110 |
Why?
| | Age Factors | 1 | 2019 | 2995 | 0.110 |
Why?
| | HLA Antigens | 1 | 2013 | 230 | 0.100 |
Why?
| | Blood Glucose | 1 | 2019 | 1939 | 0.090 |
Why?
| | Gynecologic Surgical Procedures | 2 | 2022 | 49 | 0.090 |
Why?
| | Colorado | 1 | 2019 | 4196 | 0.090 |
Why?
| | Postoperative Complications | 2 | 2018 | 2235 | 0.090 |
Why?
| | Neoplasms | 1 | 2023 | 2179 | 0.090 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 4708 | 0.090 |
Why?
| | Phenotype | 3 | 2023 | 3003 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2174 | 0.080 |
Why?
| | Emotions | 2 | 2022 | 495 | 0.080 |
Why?
| | Postoperative Period | 2 | 2017 | 309 | 0.070 |
Why?
| | Cohort Studies | 3 | 2022 | 5116 | 0.070 |
Why?
| | Autoantibodies | 1 | 2013 | 1335 | 0.070 |
Why?
| | Mental Health | 2 | 2023 | 568 | 0.060 |
Why?
| | 17-alpha-Hydroxyprogesterone | 1 | 2023 | 3 | 0.060 |
Why?
| | Androstenedione | 1 | 2023 | 10 | 0.060 |
Why?
| | Mutation | 3 | 2021 | 3457 | 0.060 |
Why?
| | Cystatin C | 1 | 2023 | 69 | 0.060 |
Why?
| | Animals | 3 | 2021 | 33381 | 0.060 |
Why?
| | Sex Chromosomes | 1 | 2023 | 48 | 0.060 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2023 | 152 | 0.060 |
Why?
| | Virilism | 1 | 2022 | 5 | 0.060 |
Why?
| | Aneuploidy | 1 | 2023 | 88 | 0.050 |
Why?
| | Menstrual Cycle | 1 | 2022 | 113 | 0.050 |
Why?
| | Sex Differentiation | 1 | 2021 | 13 | 0.050 |
Why?
| | Creatinine | 1 | 2023 | 491 | 0.050 |
Why?
| | Hirsutism | 1 | 2021 | 10 | 0.050 |
Why?
| | Karyotype | 1 | 2021 | 12 | 0.050 |
Why?
| | Chromosomes, Human, Y | 1 | 2021 | 15 | 0.050 |
Why?
| | Alopecia | 1 | 2021 | 34 | 0.050 |
Why?
| | Mammary Glands, Human | 1 | 2021 | 61 | 0.050 |
Why?
| | Health Occupations | 1 | 2021 | 30 | 0.050 |
Why?
| | Mosaicism | 1 | 2021 | 62 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 245 | 0.050 |
Why?
| | Polymicrogyria | 1 | 2019 | 6 | 0.050 |
Why?
| | Uterus | 1 | 2021 | 194 | 0.050 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 683 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2021 | 310 | 0.050 |
Why?
| | Physicians, Women | 1 | 2020 | 53 | 0.040 |
Why?
| | Canada | 1 | 2021 | 340 | 0.040 |
Why?
| | Peer Group | 1 | 2020 | 207 | 0.040 |
Why?
| | Minority Groups | 1 | 2020 | 237 | 0.040 |
Why?
| | Career Choice | 1 | 2020 | 192 | 0.040 |
Why?
| | Genitalia, Male | 1 | 2018 | 11 | 0.040 |
Why?
| | Esthetics | 1 | 2018 | 36 | 0.040 |
Why?
| | Health Status | 1 | 2023 | 726 | 0.040 |
Why?
| | Universities | 1 | 2020 | 347 | 0.040 |
Why?
| | Surgery, Plastic | 1 | 2018 | 29 | 0.040 |
Why?
| | Social Media | 1 | 2020 | 133 | 0.040 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2017 | 27 | 0.040 |
Why?
| | Occupational Exposure | 1 | 2020 | 277 | 0.040 |
Why?
| | Prevalence | 1 | 2023 | 2326 | 0.040 |
Why?
| | Precision Medicine | 1 | 2020 | 363 | 0.040 |
Why?
| | Sex Reassignment Procedures | 1 | 2016 | 3 | 0.040 |
Why?
| | Social Support | 1 | 2020 | 542 | 0.040 |
Why?
| | Hormone Antagonists | 1 | 2016 | 41 | 0.040 |
Why?
| | Societies, Medical | 1 | 2020 | 703 | 0.040 |
Why?
| | Algorithms | 1 | 2023 | 1541 | 0.030 |
Why?
| | Prejudice | 1 | 2016 | 56 | 0.030 |
Why?
| | Gonadal Dysgenesis, 46,XY | 1 | 2015 | 1 | 0.030 |
Why?
| | 46, XX Disorders of Sex Development | 1 | 2015 | 3 | 0.030 |
Why?
| | Karyotyping | 1 | 2015 | 102 | 0.030 |
Why?
| | Sleep | 1 | 2021 | 660 | 0.030 |
Why?
| | Holoprosencephaly | 1 | 2015 | 8 | 0.030 |
Why?
| | Diabetes Insipidus | 1 | 2015 | 7 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 348 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 339 | 0.030 |
Why?
| | Human Growth Hormone | 1 | 2015 | 37 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 12978 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2016 | 211 | 0.030 |
Why?
| | Thyrotropin | 1 | 2015 | 105 | 0.030 |
Why?
| | Hypogonadism | 1 | 2015 | 77 | 0.030 |
Why?
| | Curriculum | 1 | 2021 | 910 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2018 | 9342 | 0.030 |
Why?
| | United States | 2 | 2020 | 12555 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2062 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2424 | 0.030 |
Why?
| | WT1 Proteins | 1 | 2012 | 12 | 0.030 |
Why?
| | SOX9 Transcription Factor | 1 | 2012 | 24 | 0.030 |
Why?
| | RNA Splicing Factors | 1 | 2012 | 50 | 0.030 |
Why?
| | Genetic Testing | 1 | 2015 | 389 | 0.030 |
Why?
| | Depression | 1 | 2020 | 1132 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1355 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 453 | 0.030 |
Why?
| | Physicians | 1 | 2020 | 794 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2674 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2021 | 1965 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 5691 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 27617 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3057 | 0.020 |
Why?
| | Mass Screening | 1 | 2015 | 1052 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2490 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 814 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1346 | 0.020 |
Why?
| | Mice | 1 | 2021 | 15520 | 0.020 |
Why?
| | Transcription Factors | 1 | 2012 | 1570 | 0.020 |
Why?
| | Aged | 1 | 2021 | 19657 | 0.010 |
Why?
|
|
Nokoff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|